Does C79.9 require prior authorization?

No, C79.9 does not require prior authorization (high confidence). Code is covered without prior authorization.

`C79.9` — Secondary malignant neoplasm of unspecified site

ICD-10-CM

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Documentation of the qualifications of personnel performing TEE should be available upon request.
For diagnostic TEEs, report the test result if known; if not known, report the symptoms that prompted the test.
When a referring/ordering physician is required, the name and NPI of the referring/ordering physician must be reported on the claim.
Maintain copies of image documentation (paper or tape) and include all appropriate measurements; Doppler interrogations must state modes used and provide qualitative and quantitative data.

Transesophageal echocardiography (TEE) is indicated when transthoracic echocardiography (TTE) provides inadequate visualization of cardiac anatomy for structures normally visualized by TTE; report ICD-10-CM R93.1 or R93.8 as the primary diagnosis and the cardiac abnormality as a secondary diagnosis.
TEE is indicated when performed during an open chest (intraoperative) procedure; report ICD-10-CM Z01.89 as the primary diagnosis and the reason for the surgical procedure as the secondary diagnosis.
Use CPT 93315, 93316, or 93317 for evaluation of congenital cardiac anomalies (these codes are reserved for congenital anomalies only).
CPT 93355 is indicated to report TEE services performed during transcatheter intracardiac therapies and includes probe passage, image acquisition/interpretation, intra-procedural manipulation to guide sizing/placement, assessment of adequacy and complications, and final report.
3D imaging (CPT 93319) and CT/MR fusion or related add-on imaging (CPT 76376, 76377) are allowable when billed as add-on services with their listed base TEE imaging codes.
Bill Cancer TYPE ID using CPT code 81540 (mRNA gene expression assay of 92 genes) for evaluation of tumors of unknown origin.

A55147 — Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID Update

J05

L39913 — Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)

J05

L39040 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

J05

A55224 — Billing and Coding: MolDX: Germline testing for use of PARP inhibitors

J05

Ask Verity about documentation requirements, denial risks, or coverage in your state.